Based on patented DNA chain reaction that's isothermal
ETHyR Biotech is developing an innovative enzyme-free technology for DNA sequence detection.
ETHyR Biotech
It provides rapid, sensitive, cheap and automatable or point of care solutions for:
- diagnostics
- disease outbreak detection
- drug targeting
- personalised medicine
- research.
This technology is targeted at clinical pathology labs, scientific researchers, healthcare professionals, disease control institutions and households, in a $4 billion growing market.